Remember meForgot password?
    Log in with Twitter

article imageRoyal Pharmacy recalls medicinal products

By Tim Sandle     Dec 20, 2013 in Health
According to the FDA, Abrams Royal Pharmacy is voluntarily recalling all unexpired lots of sterile products dispensed nationwide due to concerns of lack of sterility assurance.
The announcement about the recall has come from the U.S. Food and Drug Administration (FDA) Medwatch service. The notice indicates that all unexpired lots of sterile compounded products are subject to the recall. According to Newsroom, the sterile products affected are injectable medications, intravenous medicines, eye drops, pellet implants, nasal sprays, inhalation solutions, and eye ointments.
The recall was issued after a single, isolated report of an adverse event involving a patient in California who received a compounded medication from the pharmacy. As a cautionary measure Abrams Royal decided to voluntarily recall all sterile products within expiry. If there is microbial contamination in products intended to be sterile, patients are at risk for serious, potentially life-threatening infections.
The recalled products were distributed to health care facilities, physicians, and patients from June 17, 2013, through December 17, 2013.
More about Pharmacy, Recall, Sterile, Medicine
More news from
Latest News
Top News